Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MICROSEMI CORPMSCC · Entity 166236 | Exec VP Worldwide Sales & Mktg | May 29, 2018 | May 30, 2018 |
| MOBIX LABS, INCMOBX · Entity 7651 | Director | September 14, 2026 | September 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MICROSEMI CORP
Report date May 29, 2018 · Filed May 30, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Microsemi Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-05-29 transaction · row 1
1 source rowRow 1 · 2018-05-29 · Disposition to issuer · Disposed 57,262 · Balance 0 F1: Shares disposed of pursuant to the Agreement and Plan of Merger by and among Microchip Technology Incorporated ("Microchip") , Maple Acquisition Corporation and Microsemi Corporation (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), whereby each share of Issuer's common stock was automatically cancelled and converted into the right to an amount equal to $68.78 in cash (the "Merger Consideration"). |
| Microsemi Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-05-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-05-29 · Disposition to issuer · Disposed 18,294 · Balance 0 F2: Pursuant to the Merger Agreement, this Restricted Stock Unit ("RSU") was assumed and converted in the Merger into that number of Microchip RSUs of Microchip common stock equal to the product of (a) this number of RSUs and (b) the "Equity Award Exchange Ratio" obtained by dividing the Merger Consideration of $68.78 by the average closing sales price for a share of Microchip common stock, rounded to the nearest one-tenth of a cent, as reported on Nasdaq for the ten (10) most recent days ending on the last trading day immediately prior to the date on which the Effective Time occurs, calculated as 0.732185. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares disposed of pursuant to the Agreement and Plan of Merger by and among Microchip Technology Incorporated ("Microchip") , Maple Acquisition Corporation and Microsemi Corporation (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), whereby each share of Issuer's common stock was automatically cancelled and converted into the right to an amount equal to $68.78 in cash (the "Merger Consideration").
F2: Pursuant to the Merger Agreement, this Restricted Stock Unit ("RSU") was assumed and converted in the Merger into that number of Microchip RSUs of Microchip common stock equal to the product of (a) this number of RSUs and (b) the "Equity Award Exchange Ratio" obtained by dividing the Merger Consideration of $68.78 by the average closing sales price for a share of Microchip common stock, rounded to the nearest one-tenth of a cent, as reported on Nasdaq for the ten (10) most recent days ending on the last trading day immediately prior to the date on which the Effective Time occurs, calculated as 0.732185.
MOBIX LABS, INC
Report date September 14, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 238,812 |
Ending reported balance
After 2026-09-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-14 · Grant · Acquired 12,255 · Balance 219,711 F1: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on September 30, 2026. Row 2 · 2026-09-14 · Grant · Acquired 19,101 · Balance 238,812 F2: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on October 1, 2026. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.80 · Expires 2030-08-10 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 2,000 F3: These options are fully vested and exercisable. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.40 · Expires 2032-04-04 | Direct | 13,341 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 13,341 F3: These options are fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on September 30, 2026.
F2: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on October 1, 2026.
F3: These options are fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 22, 2026 22:20 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 19,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-043763 · ownership.xml · nonDerivative · entry 2 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,812 F2 · shares: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on October 1, 2026. Read SEC document |
| September 14, 2026 Filed Sep 22, 2026 22:20 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 12,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-043763 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,711 F1 · shares: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on September 30, 2026. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:26 UTC | MOBIX LABS, INC MOBX · Entity 7651 | ConversionClass B Common Stock · Derivative | 21,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-040131 · ownership.xml · derivative · entry 4 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 21,739 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents the conversion, on a one-for-one basis, of all the 21,739 shares of Class B Common Stock held by the Reporting Person into 21,739 shares of Class A Common Stock, pursuant to the terms of the Company's Certificate of Incorporation. No consideration was paid in connection with the conversion. F2 · derivative.exercise_date: Represents the conversion, on a one-for-one basis, of all the 21,739 shares of Class B Common Stock held by the Reporting Person into 21,739 shares of Class A Common Stock, pursuant to the terms of the Company's Certificate of Incorporation. No consideration was paid in connection with the conversion. F2 · derivative.expiration_date: Represents the conversion, on a one-for-one basis, of all the 21,739 shares of Class B Common Stock held by the Reporting Person into 21,739 shares of Class A Common Stock, pursuant to the terms of the Company's Certificate of Incorporation. No consideration was paid in connection with the conversion. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:26 UTC | MOBIX LABS, INC MOBX · Entity 7651 | ConversionClass A Common Stock | 21,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-040131 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 22:29 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 13,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-031999 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,717 F1 · shares: These Restricted Stock Units were granted to the Reporting Person on June 30, 2026 and vested on July 1, 2026. Read SEC document |
| March 30, 2026 Filed May 5, 2026 01:34 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-021207 · ownership.xml · nonDerivative · entry 2 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,057 Read SEC document |
| February 25, 2026 Filed May 5, 2026 01:34 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 14,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-021207 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,057 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on February 25, 2026 and vested on April 1, 2026. F2 · balance_after: The number of shares beneficially owned by the Reporting Person has been adjusted to account for rounding as a result of a 1-for-10 reverse stock split effected by the Issuer on April 6, 2026. Read SEC document |
| November 25, 2025 Filed Nov 29, 2025 00:50 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 39,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025465 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,522,546 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on November 25, 2025 and will vest on January 1, 2026. Read SEC document |
| September 23, 2025 Filed Sep 26, 2025 00:32 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 46,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-015013 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,483,380 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on September 23, 2025. Read SEC document |
| July 09, 2025 Filed Jul 11, 2025 20:48 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 131,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-018786 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,436,525 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on July 9, 2025, whereas 90% of the award was fully vested upon grant and the remaining 10% will vest on October 1, 2025. Read SEC document |
| May 30, 2025 Filed Aug 14, 2025 00:35 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass B Common Stock · Derivative | 915,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-011925 · ownership.xml · derivative · entry 5 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 915,033 Underlying: Class A Common Stock · 915,033 shares Expires not disclosed F2 · derivative.exercise_price: The shares of Class B Common Stock are convertible into shares of Class A Common Stock at the option of the Reporting Person, and will be automatically converted upon (i) a transfer by the Reporting Person (other than a permitted transfer) or (ii) the first trading day after the seventh anniversary date of the Closing Date (December 21, 2023). F3 · derivative.exercise_date: The Class B restricted stock awards (the "RSAs") were granted to the Reporting Person on May 30, 2025, and will vest over five years as follows: (i) 10% of the RSAs will vest on the first anniversary of the grant date (May 30, 2026) and (ii) the remaining 90% will vest in equal quarterly installments over the remaining 48 months. F3 · derivative.expiration_date: The Class B restricted stock awards (the "RSAs") were granted to the Reporting Person on May 30, 2025, and will vest over five years as follows: (i) 10% of the RSAs will vest on the first anniversary of the grant date (May 30, 2026) and (ii) the remaining 90% will vest in equal quarterly installments over the remaining 48 months. Read SEC document |
| April 11, 2025 Filed May 12, 2025 23:30 UTC Amendment | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 1,050,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-009776 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,305,169 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on April 11, 2025 and are fully vested on the grant date. These RSUs will settle and be delivered on the earlier of: (i) Participant's separation from service; (ii) Participant's disability; (iii) Participant's death; (iv) Change in Control of the Company; (v) occurrence of an unforeseeable emergency for the Participant as defined under Section 409A of the Internal Revenue Code; or (vi) on the following dates: (a) 350,000 RSUs on April 4, 2026; (b) 350,000 RSUs on July 1, 2026; and (c) 350,000 RSUs on November 1, 2026. F2 · shares: On April 14, 2025, the Reporting Person filed a Form 4 with an incorrect footnote on the award given due to an administrative error. This amendment reflects the correct footnote for the award. Read SEC document |
| April 10, 2025 Filed Apr 15, 2025 01:00 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 1,050,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-004666 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,305,169 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on April 10, 2025 and are fully vested on the grant date (April 10, 2025). Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:59 UTC | MOBIX LABS, INC MOBX · Entity 7651 | SaleClass A Common Stock | 5,020 | $1.35 | $6,780.51 |
DisclosureSEC source: 0001493152-25-008230 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,169 F1 · price: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $1.35 to $1.355 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| February 20, 2025 Filed Feb 22, 2025 00:03 UTC | MOBIX LABS, INC MOBX · Entity 7651 | SaleClass A Common Stock | 1,328 | $1.35 | $1,792.80 |
DisclosureSEC source: 0001493152-25-007946 · ownership.xml · nonDerivative · entry 2 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,189 Read SEC document |
| February 19, 2025 Filed Feb 22, 2025 00:03 UTC | MOBIX LABS, INC MOBX · Entity 7651 | SaleClass A Common Stock | 1,928 | $1.35 | $2,602.80 |
DisclosureSEC source: 0001493152-25-007946 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,517 Read SEC document |
| December 21, 2023 Filed Dec 27, 2023 02:51 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass B Common Stock · Derivative | 217,391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-129363 · tm2333669-12_4seq1.xml · derivative · entry 2 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,391 Underlying: Class A Common Stock · 217,391 shares Expires not disclosed F2 · derivative.exercise_price: At the Closing Date, the Reporting Person acquired these shares in exchange for the same number of shares of preferred stock, which includes Series A Preferred Stock and Founders Preferred Stock of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class B Common Stock. The shares of Class B Common Stock are convertible into shares of Class A Common Stock at the option of the Reporting Person, and will be automatically converted upon (i) a transfer by the Reporting Person (other than a permitted transfer) or (ii) the first trading day after the seventh anniversary date of the Closing Date. F2 · price: At the Closing Date, the Reporting Person acquired these shares in exchange for the same number of shares of preferred stock, which includes Series A Preferred Stock and Founders Preferred Stock of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class B Common Stock. The shares of Class B Common Stock are convertible into shares of Class A Common Stock at the option of the Reporting Person, and will be automatically converted upon (i) a transfer by the Reporting Person (other than a permitted transfer) or (ii) the first trading day after the seventh anniversary date of the Closing Date. F2 · derivative.exercise_date: At the Closing Date, the Reporting Person acquired these shares in exchange for the same number of shares of preferred stock, which includes Series A Preferred Stock and Founders Preferred Stock of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class B Common Stock. The shares of Class B Common Stock are convertible into shares of Class A Common Stock at the option of the Reporting Person, and will be automatically converted upon (i) a transfer by the Reporting Person (other than a permitted transfer) or (ii) the first trading day after the seventh anniversary date of the Closing Date. F2 · derivative.expiration_date: At the Closing Date, the Reporting Person acquired these shares in exchange for the same number of shares of preferred stock, which includes Series A Preferred Stock and Founders Preferred Stock of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class B Common Stock. The shares of Class B Common Stock are convertible into shares of Class A Common Stock at the option of the Reporting Person, and will be automatically converted upon (i) a transfer by the Reporting Person (other than a permitted transfer) or (ii) the first trading day after the seventh anniversary date of the Closing Date. Read SEC document |
| December 21, 2023 Filed Dec 27, 2023 02:51 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 317,244 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-129363 · tm2333669-12_4seq1.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,244 F1 · shares: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock. F1 · price: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock. Read SEC document |
| December 21, 2023 Filed Feb 21, 2025 23:47 UTC Amendment | MOBIX LABS, INC MOBX · Entity 7651 | GrantOption (Right to Buy) · Derivative | 133,416 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001493152-25-007944 · ownership.xml · derivative · entry 3 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,416 Underlying: Class A Common Stock · 133,416 shares Expires 2032-04-04 F1 · security: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. F2 · security: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares and options in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock as well as options exercisable into shares of Class A Common Stock. F3 · derivative.exercise_date: These options are fully vested and exercisable. F1 · balance_after: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. Read SEC document |
| December 21, 2023 Filed Feb 21, 2025 23:47 UTC Amendment | MOBIX LABS, INC MOBX · Entity 7651 | GrantOption (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001493152-25-007944 · ownership.xml · derivative · entry 2 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Class A Common Stock · 20,000 shares Expires 2030-08-10 F1 · security: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. F2 · security: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares and options in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock as well as options exercisable into shares of Class A Common Stock. F3 · derivative.exercise_date: These options are fully vested and exercisable. F1 · balance_after: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. Read SEC document |
| December 21, 2023 Filed Feb 21, 2025 23:47 UTC Amendment | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 263,445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-007944 · ownership.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,445 F1 · shares: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. F2 · shares: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares and options in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock as well as options exercisable into shares of Class A Common Stock. F1 · price: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. F1 · balance_after: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. F2 · balance_after: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares and options in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock as well as options exercisable into shares of Class A Common Stock. Read SEC document |
| May 29, 2018 Filed May 30, 2018 16:36 UTC | MICROSEMI CORP MSCC · Entity 166236 | Disposition to issuerMicrosemi Restricted Stock Units · Derivative | 18,294 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310568-18-000107 · wf-form4_152771259163686.xml · derivative · entry 2 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,294 shares Expires not disclosed F2 · derivative.exercise_price: Pursuant to the Merger Agreement, this Restricted Stock Unit ("RSU") was assumed and converted in the Merger into that number of Microchip RSUs of Microchip common stock equal to the product of (a) this number of RSUs and (b) the "Equity Award Exchange Ratio" obtained by dividing the Merger Consideration of $68.78 by the average closing sales price for a share of Microchip common stock, rounded to the nearest one-tenth of a cent, as reported on Nasdaq for the ten (10) most recent days ending on the last trading day immediately prior to the date on which the Effective Time occurs, calculated as 0.732185. F2 · price: Pursuant to the Merger Agreement, this Restricted Stock Unit ("RSU") was assumed and converted in the Merger into that number of Microchip RSUs of Microchip common stock equal to the product of (a) this number of RSUs and (b) the "Equity Award Exchange Ratio" obtained by dividing the Merger Consideration of $68.78 by the average closing sales price for a share of Microchip common stock, rounded to the nearest one-tenth of a cent, as reported on Nasdaq for the ten (10) most recent days ending on the last trading day immediately prior to the date on which the Effective Time occurs, calculated as 0.732185. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, this Restricted Stock Unit ("RSU") was assumed and converted in the Merger into that number of Microchip RSUs of Microchip common stock equal to the product of (a) this number of RSUs and (b) the "Equity Award Exchange Ratio" obtained by dividing the Merger Consideration of $68.78 by the average closing sales price for a share of Microchip common stock, rounded to the nearest one-tenth of a cent, as reported on Nasdaq for the ten (10) most recent days ending on the last trading day immediately prior to the date on which the Effective Time occurs, calculated as 0.732185. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, this Restricted Stock Unit ("RSU") was assumed and converted in the Merger into that number of Microchip RSUs of Microchip common stock equal to the product of (a) this number of RSUs and (b) the "Equity Award Exchange Ratio" obtained by dividing the Merger Consideration of $68.78 by the average closing sales price for a share of Microchip common stock, rounded to the nearest one-tenth of a cent, as reported on Nasdaq for the ten (10) most recent days ending on the last trading day immediately prior to the date on which the Effective Time occurs, calculated as 0.732185. Read SEC document |
| May 29, 2018 Filed May 30, 2018 16:36 UTC | MICROSEMI CORP MSCC · Entity 166236 | Disposition to issuerMicrosemi Common Stock | 57,262 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310568-18-000107 · wf-form4_152771259163686.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Shares disposed of pursuant to the Agreement and Plan of Merger by and among Microchip Technology Incorporated ("Microchip") , Maple Acquisition Corporation and Microsemi Corporation (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), whereby each share of Issuer's common stock was automatically cancelled and converted into the right to an amount equal to $68.78 in cash (the "Merger Consideration"). Read SEC document |
| April 25, 2018 Filed Apr 27, 2018 16:21 UTC | MICROSEMI CORP MSCC · Entity 166236 | Tax withholdingMicrosemi Common Stock | 842 | $64.30 | $54,140.60 |
DisclosureSEC source: 0000310568-18-000078 · wf-form4_152486047000165.xml · nonDerivative · entry 2 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,262 Read SEC document |
| April 25, 2018 Filed Apr 27, 2018 16:21 UTC | MICROSEMI CORP MSCC · Entity 166236 | GrantMicrosemi Common Stock | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-18-000078 · wf-form4_152486047000165.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,104 F1 · security: Shares issued by Microsemi as part of the reporting person's bonus for the first half of fiscal year 2018. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 17:04 UTC | MICROSEMI CORP MSCC · Entity 166236 | SaleMicrosemi Common Stock | 2,102 | $64.76 | $136,129.51 |
DisclosureSEC source: 0000310568-18-000066 · wf-form4_152330785645542.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,692 F1 · security: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 21:41 UTC | MICROSEMI CORP MSCC · Entity 166236 | GrantMicrosemi Restricted Stock Units · Derivative | 18,294 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-18-000062 · wf-form4_152280607000521.xml · derivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,294 Underlying: Common Stock · 18,294 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right, subject to vesting, to receive one share of Microsemi common stock. The award is scheduled to vest 40% on September 30, 2019, 30% on September 30, 2020, and 30% on September 30, 2021, subject to accelerated vesting in certain circumstances. Microsemi may also add performance-based vesting requirements to the award in certain circumstances. F1 · derivative.exercise_date: Each Restricted Stock Unit represents a right, subject to vesting, to receive one share of Microsemi common stock. The award is scheduled to vest 40% on September 30, 2019, 30% on September 30, 2020, and 30% on September 30, 2021, subject to accelerated vesting in certain circumstances. Microsemi may also add performance-based vesting requirements to the award in certain circumstances. F1 · derivative.expiration_date: Each Restricted Stock Unit represents a right, subject to vesting, to receive one share of Microsemi common stock. The award is scheduled to vest 40% on September 30, 2019, 30% on September 30, 2020, and 30% on September 30, 2021, subject to accelerated vesting in certain circumstances. Microsemi may also add performance-based vesting requirements to the award in certain circumstances. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 18:02 UTC | MICROSEMI CORP MSCC · Entity 166236 | SaleMicrosemi Common Stock | 3,968 | $51.51 | $204,396.84 |
DisclosureSEC source: 0000310568-17-000238 · wf-form4_151311974710527.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,794 F1 · security: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 18:43 UTC | MICROSEMI CORP MSCC · Entity 166236 | Tax withholdingMicrosemi Common Stock | 2,063 | $52.91 | $109,153.33 |
DisclosureSEC source: 0000310568-17-000229 · wf-form4_151096220905345.xml · nonDerivative · entry 2 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,762 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 18:43 UTC | MICROSEMI CORP MSCC · Entity 166236 | GrantMicrosemi Common Stock | 3,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-17-000229 · wf-form4_151096220905345.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,825 F1 · security: Shares issued by Microsemi as part of the reporting person's bonus for fiscal year 2017. Read SEC document |
| November 09, 2017 Filed Nov 9, 2017 21:27 UTC | MICROSEMI CORP MSCC · Entity 166236 | Exercise / conversionPerformance Rights · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-17-000212 · wf-form4_151028085921323.xml · derivative · entry 3 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Microsemi Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Performance Right represents a right to receive one share of Microsemi common stock. The target number of 15,271 Performance Rights was granted on 10/10/16 and between 0% and 270% of the target number will be earned over a three-year performance period incorporating Microsemi's fiscal year 2017, 2018 and 2019. This transaction reflects the number of shares earned in the first year of the performance period. F1 · derivative.exercise_date: Each Performance Right represents a right to receive one share of Microsemi common stock. The target number of 15,271 Performance Rights was granted on 10/10/16 and between 0% and 270% of the target number will be earned over a three-year performance period incorporating Microsemi's fiscal year 2017, 2018 and 2019. This transaction reflects the number of shares earned in the first year of the performance period. F1 · derivative.expiration_date: Each Performance Right represents a right to receive one share of Microsemi common stock. The target number of 15,271 Performance Rights was granted on 10/10/16 and between 0% and 270% of the target number will be earned over a three-year performance period incorporating Microsemi's fiscal year 2017, 2018 and 2019. This transaction reflects the number of shares earned in the first year of the performance period. F1 · balance_after: Each Performance Right represents a right to receive one share of Microsemi common stock. The target number of 15,271 Performance Rights was granted on 10/10/16 and between 0% and 270% of the target number will be earned over a three-year performance period incorporating Microsemi's fiscal year 2017, 2018 and 2019. This transaction reflects the number of shares earned in the first year of the performance period. Read SEC document |
| November 09, 2017 Filed Nov 9, 2017 21:27 UTC | MICROSEMI CORP MSCC · Entity 166236 | Tax withholdingMicrosemi Common Stock | 2,479 | $55.16 | $136,741.64 |
DisclosureSEC source: 0000310568-17-000212 · wf-form4_151028085921323.xml · nonDerivative · entry 2 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,873 Read SEC document |
| November 09, 2017 Filed Nov 9, 2017 21:27 UTC | MICROSEMI CORP MSCC · Entity 166236 | Exercise / conversionMicrosemi Common Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-17-000212 · wf-form4_151028085921323.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 19:46 UTC | MICROSEMI CORP MSCC · Entity 166236 | SaleMicrosemi Common Stock | 3,000 | $55.00 | $165,000.00 |
DisclosureSEC source: 0000310568-17-000195 · wf-form4_151018834664299.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,602 F1 · security: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| October 20, 2017 Filed Oct 24, 2017 18:32 UTC | MICROSEMI CORP MSCC · Entity 166236 | Exercise / conversionMicrosemi Restricted Stock Units · Derivative | 10,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000310568-17-000183 · wf-form4_150888431047853.xml · derivative · entry 3 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Microsemi Common Stock · 10,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This transaction reports the vesting of awards of restricted stock units and settlement in Microsemi Common Stock on the dates indicated. Each restricted stock unit represents a contingent right to receive one share of Microsemi Common Stock. F1 · derivative.exercise_date: This transaction reports the vesting of awards of restricted stock units and settlement in Microsemi Common Stock on the dates indicated. Each restricted stock unit represents a contingent right to receive one share of Microsemi Common Stock. F1 · derivative.expiration_date: This transaction reports the vesting of awards of restricted stock units and settlement in Microsemi Common Stock on the dates indicated. Each restricted stock unit represents a contingent right to receive one share of Microsemi Common Stock. Read SEC document |
| October 20, 2017 Filed Oct 24, 2017 18:32 UTC | MICROSEMI CORP MSCC · Entity 166236 | SaleMicrosemi Common Stock | 5,167 | $51.72 | $267,243.96 |
DisclosureSEC source: 0000310568-17-000183 · wf-form4_150888431047853.xml · nonDerivative · entry 2 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,602 F2 · security: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| October 20, 2017 Filed Oct 24, 2017 18:32 UTC | MICROSEMI CORP MSCC · Entity 166236 | Exercise / conversionMicrosemi Common Stock | 10,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310568-17-000183 · wf-form4_150888431047853.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction reports the vesting of awards of restricted stock units and settlement in Microsemi Common Stock on the dates indicated. Each restricted stock unit represents a contingent right to receive one share of Microsemi Common Stock. F1 · price: This transaction reports the vesting of awards of restricted stock units and settlement in Microsemi Common Stock on the dates indicated. Each restricted stock unit represents a contingent right to receive one share of Microsemi Common Stock. Read SEC document |
| October 10, 2017 Filed Oct 10, 2017 17:55 UTC | MICROSEMI CORP MSCC · Entity 166236 | SaleMicrosemi Common Stock | 5,000 | $52.33 | $261,631.00 |
DisclosureSEC source: 0000310568-17-000160 · wf-form4_150767250860019.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,436 F1 · security: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 17:54 UTC | MICROSEMI CORP MSCC · Entity 166236 | SaleMicrosemi Common Stock | 1,500 | $50.12 | $75,173.85 |
DisclosureSEC source: 0000310568-17-000141 · wf-form4_150430282979727.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,436 Read SEC document |
| August 04, 2017 Filed Aug 4, 2017 19:29 UTC | MICROSEMI CORP MSCC · Entity 166236 | SaleMicrosemi Common Stock | 1,500 | $51.61 | $77,418.15 |
DisclosureSEC source: 0000310568-17-000133 · wf-form4_150188935729585.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,936 Read SEC document |
| May 19, 2017 Filed May 23, 2017 19:42 UTC | MICROSEMI CORP MSCC · Entity 166236 | Tax withholdingMicrosemi Common Stock | 314 | $47.94 | $15,053.16 |
DisclosureSEC source: 0000310568-17-000097 · wf-form4_149558296414242.xml · nonDerivative · entry 2 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,436 Read SEC document |
| May 19, 2017 Filed May 23, 2017 19:42 UTC | MICROSEMI CORP MSCC · Entity 166236 | GrantMicrosemi Common Stock | 834 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-17-000097 · wf-form4_149558296414242.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,750 F1 · security: Issuance of stock by Microsemi to satisfy accrued vacation time obligations. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 16:23 UTC | MICROSEMI CORP MSCC · Entity 166236 | Tax withholdingMicrosemi Common Stock | 700 | $48.99 | $34,293.00 |
DisclosureSEC source: 0000310568-17-000066 · wf-form4_149341100322610.xml · nonDerivative · entry 2 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,916 Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 16:23 UTC | MICROSEMI CORP MSCC · Entity 166236 | GrantMicrosemi Common Stock | 1,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-17-000066 · wf-form4_149341100322610.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,616 F1 · security: Shares issued by Microsemi as part of the reporting person's bonus for the first half of fiscal year 2017. Read SEC document |
| April 05, 2017 Filed Apr 6, 2017 18:19 UTC | MICROSEMI CORP MSCC · Entity 166236 | SaleMicrosemi Common Stock | 2,000 | $50.89 | $101,780.00 |
DisclosureSEC source: 0000310568-17-000047 · wf-form4_149151715792844.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,782 F1 · security: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 19:59 UTC | MICROSEMI CORP MSCC · Entity 166236 | SaleMicrosemi Common Stock | 2,008 | $55.91 | $112,267.28 |
DisclosureSEC source: 0000310568-17-000004 · wf-form4_148487394220069.xml · nonDerivative · entry 1 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,782 F1 · security: The transaction reported on this form was executed pursuant to a 10b5-1 plan. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 20:54 UTC | MICROSEMI CORP MSCC · Entity 166236 | GrantPerformance Rights · Derivative | 15,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-16-000483 · wf-form4_148159408083140.xml · derivative · entry 8 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,271 Underlying: Microsemi Common Stock · 15,271 shares Expires not disclosed F4 · derivative.exercise_price: Each Performance Right represents a right to receive one share of Microsemi common stock. The target number of Performance Rights is indicated. Between 0% and 270% of the target number will be earned over a three-year performance period incorporating Microsemi's fiscal year 2017, 2018 and 2019, and based on revenue, adjusted earnings per share metrics and total shareholder return relative to a peer group of companies. A portion of the shares may be earned based on performance in each year of the performance period. F4 · derivative.exercise_date: Each Performance Right represents a right to receive one share of Microsemi common stock. The target number of Performance Rights is indicated. Between 0% and 270% of the target number will be earned over a three-year performance period incorporating Microsemi's fiscal year 2017, 2018 and 2019, and based on revenue, adjusted earnings per share metrics and total shareholder return relative to a peer group of companies. A portion of the shares may be earned based on performance in each year of the performance period. F4 · derivative.expiration_date: Each Performance Right represents a right to receive one share of Microsemi common stock. The target number of Performance Rights is indicated. Between 0% and 270% of the target number will be earned over a three-year performance period incorporating Microsemi's fiscal year 2017, 2018 and 2019, and based on revenue, adjusted earnings per share metrics and total shareholder return relative to a peer group of companies. A portion of the shares may be earned based on performance in each year of the performance period. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 20:54 UTC | MICROSEMI CORP MSCC · Entity 166236 | Tax withholdingMicrosemi Common Stock | 1,517 | $56.72 | $86,044.24 |
DisclosureSEC source: 0000310568-16-000483 · wf-form4_148159408083140.xml · nonDerivative · entry 5 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,790 Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 20:54 UTC | MICROSEMI CORP MSCC · Entity 166236 | GrantMicrosemi Common Stock | 2,906 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-16-000483 · wf-form4_148159408083140.xml · nonDerivative · entry 4 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,307 F3 · security: Shares issued by Microsemi as part of the reporting person's bonus for fiscal year 2016. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 20:54 UTC | MICROSEMI CORP MSCC · Entity 166236 | GrantMicrosemi Common Stock | 5,090 | $0.00 | $0.00 |
DisclosureSEC source: 0000310568-16-000483 · wf-form4_148159408083140.xml · nonDerivative · entry 3 Goerner Frederick C · CIK 0001429299 · Exec VP Worldwide Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,401 F2 · security: Award of shares is scheduled to vest, subject to the reporting person's continued employment, over a three year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.